Evolus Basic Shares Outstanding 2016-2024 | EOLS
Evolus basic shares outstanding from 2016 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
| Evolus Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $62 |
| 2023 | $57 |
| 2022 | $56 |
| 2021 | $50 |
| 2020 | $34 |
| 2019 | $28 |
| 2018 | $24 |
| 2017 | $17 |
| 2016 | $17 |
| 2015 | $17 |
| Evolus Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024-12-31 | $62 |
| 2024-09-30 | $63 |
| 2024-06-30 | $63 |
| 2024-03-31 | $59 |
| 2023-12-31 | $57 |
| 2023-09-30 | $57 |
| 2023-06-30 | $57 |
| 2023-03-31 | $56 |
| 2022-12-31 | $56 |
| 2022-09-30 | $56 |
| 2022-06-30 | $56 |
| 2022-03-31 | $56 |
| 2021-12-31 | $50 |
| 2021-09-30 | $55 |
| 2021-06-30 | $51 |
| 2021-03-31 | $37 |
| 2020-12-31 | $34 |
| 2020-09-30 | $34 |
| 2020-06-30 | $34 |
| 2020-03-31 | $34 |
| 2019-12-31 | $28 |
| 2019-09-30 | $27 |
| 2019-06-30 | $27 |
| 2019-03-31 | $27 |
| 2018-12-31 | $24 |
| 2018-09-30 | $25 |
| 2018-06-30 | $24 |
| 2018-03-31 | $20 |
| 2017-12-31 | $18 |
| 2017-09-30 | $17 |
| 2017-06-30 | $17 |
| 2017-03-31 | $17 |
| 2016-12-31 | |
| 2015-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.779B | $0.266B |
| Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California. | |||